Taken together, these observations call for the systematic search of nutraceuticals with CFTR-rescuing potential for treatment in cystic fibrosis, an aim that may be achieved by drug repositioning that has already been used both for cystic fibrosis [23,24] and for screening natural products in various pathological settings [84]. This evidence concerns the gene CFTR and cystic fibrosis.